Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WHO Clears Rubella Vaccine In Death Of Sri Lanka Child

This article was originally published in PharmAsia News

Executive Summary

A UN agency official told Sri Lanka authorities a rubella vaccine given to a child who later died was not contaminated or compromised. The World Health Organization said the batch from which the Sri Lanka vaccine was taken has been used in five other countries without a single report of a complication. A student died and 17 students were hospitalized after being administered the vaccine, leading to a suspension of its use in the country. Based on the WHO report, the Healthcare and Nutrition Ministry decided to resume the rubella vaccine program within the next two months after special training of health professionals. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071226

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel